vs

Side-by-side financial comparison of KKR Real Estate Finance Trust Inc. (KREF) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.

KKR Real Estate Finance Trust Inc. is the larger business by last-quarter revenue ($25.8M vs $13.3M, roughly 1.9× OCULAR THERAPEUTIX, INC). KKR Real Estate Finance Trust Inc. runs the higher net margin — -101.7% vs -488.0%, a 386.2% gap on every dollar of revenue. On growth, OCULAR THERAPEUTIX, INC posted the faster year-over-year revenue change (-22.4% vs -26.6%). Over the past eight quarters, OCULAR THERAPEUTIX, INC's revenue compounded faster (-5.3% CAGR vs -18.8%).

KKR Real Estate Finance Trust Inc. is a specialized real estate finance firm sponsored by global investment firm KKR. It primarily originates, acquires, and manages a portfolio of senior secured commercial real estate loans, mostly backed by high-quality institutional commercial properties across the United States, delivering stable risk-adjusted returns to investors via interest income from its diversified assets.

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

KREF vs OCUL — Head-to-Head

Bigger by revenue
KREF
KREF
1.9× larger
KREF
$25.8M
$13.3M
OCUL
Growing faster (revenue YoY)
OCUL
OCUL
+4.2% gap
OCUL
-22.4%
-26.6%
KREF
Higher net margin
KREF
KREF
386.2% more per $
KREF
-101.7%
-488.0%
OCUL
Faster 2-yr revenue CAGR
OCUL
OCUL
Annualised
OCUL
-5.3%
-18.8%
KREF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KREF
KREF
OCUL
OCUL
Revenue
$25.8M
$13.3M
Net Profit
$-26.2M
$-64.7M
Gross Margin
88.0%
Operating Margin
-105.1%
-526.5%
Net Margin
-101.7%
-488.0%
Revenue YoY
-26.6%
-22.4%
Net Profit YoY
-229.6%
-33.6%
EPS (diluted)
$-0.49
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KREF
KREF
OCUL
OCUL
Q4 25
$25.8M
$13.3M
Q3 25
$25.3M
$14.5M
Q2 25
$30.2M
$13.5M
Q1 25
$31.3M
$10.7M
Q4 24
$35.1M
$17.1M
Q3 24
$37.0M
$15.4M
Q2 24
$40.4M
$16.4M
Q1 24
$39.1M
$14.8M
Net Profit
KREF
KREF
OCUL
OCUL
Q4 25
$-26.2M
$-64.7M
Q3 25
$13.8M
$-69.4M
Q2 25
$-29.7M
$-67.8M
Q1 25
$-4.9M
$-64.1M
Q4 24
$20.3M
$-48.4M
Q3 24
$-7.4M
$-36.5M
Q2 24
$25.8M
$-43.8M
Q1 24
$-3.1M
$-64.8M
Gross Margin
KREF
KREF
OCUL
OCUL
Q4 25
88.0%
Q3 25
87.8%
Q2 25
85.6%
Q1 25
88.2%
Q4 24
92.8%
Q3 24
89.9%
Q2 24
90.8%
Q1 24
91.0%
Operating Margin
KREF
KREF
OCUL
OCUL
Q4 25
-105.1%
-526.5%
Q3 25
50.4%
-472.3%
Q2 25
-101.3%
-502.6%
Q1 25
-18.3%
-597.5%
Q4 24
55.8%
-296.1%
Q3 24
-19.6%
-298.2%
Q2 24
63.3%
-265.1%
Q1 24
-8.7%
-214.0%
Net Margin
KREF
KREF
OCUL
OCUL
Q4 25
-101.7%
-488.0%
Q3 25
54.4%
-477.3%
Q2 25
-98.5%
-503.9%
Q1 25
-15.5%
-598.7%
Q4 24
57.7%
-283.3%
Q3 24
-20.0%
-236.6%
Q2 24
63.9%
-266.3%
Q1 24
-7.9%
-438.9%
EPS (diluted)
KREF
KREF
OCUL
OCUL
Q4 25
$-0.49
$-0.27
Q3 25
$0.12
$-0.38
Q2 25
$-0.53
$-0.39
Q1 25
$-0.15
$-0.38
Q4 24
$0.22
$-0.25
Q3 24
$-0.19
$-0.22
Q2 24
$0.29
$-0.26
Q1 24
$-0.13
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KREF
KREF
OCUL
OCUL
Cash + ST InvestmentsLiquidity on hand
$84.6M
$737.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.2B
$654.3M
Total Assets
$6.5B
$808.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KREF
KREF
OCUL
OCUL
Q4 25
$84.6M
$737.1M
Q3 25
$204.1M
$344.8M
Q2 25
$107.7M
$391.1M
Q1 25
$106.4M
$349.7M
Q4 24
$104.9M
$392.1M
Q3 24
$108.8M
$427.2M
Q2 24
$107.2M
$459.7M
Q1 24
$106.5M
$482.9M
Stockholders' Equity
KREF
KREF
OCUL
OCUL
Q4 25
$1.2B
$654.3M
Q3 25
$1.2B
$258.2M
Q2 25
$1.2B
$305.9M
Q1 25
$1.3B
$265.9M
Q4 24
$1.3B
$315.3M
Q3 24
$1.4B
$352.0M
Q2 24
$1.4B
$377.7M
Q1 24
$1.4B
$408.0M
Total Assets
KREF
KREF
OCUL
OCUL
Q4 25
$6.5B
$808.1M
Q3 25
$6.5B
$410.9M
Q2 25
$6.8B
$451.3M
Q1 25
$6.6B
$405.9M
Q4 24
$6.4B
$457.9M
Q3 24
$6.8B
$490.4M
Q2 24
$7.1B
$517.1M
Q1 24
$7.3B
$538.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KREF
KREF
OCUL
OCUL
Operating Cash FlowLast quarter
$72.3M
$-54.2M
Free Cash FlowOCF − Capex
$-57.1M
FCF MarginFCF / Revenue
-430.9%
Capex IntensityCapex / Revenue
21.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KREF
KREF
OCUL
OCUL
Q4 25
$72.3M
$-54.2M
Q3 25
$18.5M
$-50.7M
Q2 25
$21.1M
$-55.2M
Q1 25
$15.9M
$-44.7M
Q4 24
$132.6M
$-39.4M
Q3 24
$49.1M
$-36.6M
Q2 24
$30.6M
$-24.8M
Q1 24
$34.5M
$-33.9M
Free Cash Flow
KREF
KREF
OCUL
OCUL
Q4 25
$-57.1M
Q3 25
$-56.7M
Q2 25
$-56.5M
Q1 25
$-46.6M
Q4 24
$-39.6M
Q3 24
$-36.6M
Q2 24
$-25.5M
Q1 24
$-34.1M
FCF Margin
KREF
KREF
OCUL
OCUL
Q4 25
-430.9%
Q3 25
-390.0%
Q2 25
-419.7%
Q1 25
-435.6%
Q4 24
-232.0%
Q3 24
-237.6%
Q2 24
-155.4%
Q1 24
-231.1%
Capex Intensity
KREF
KREF
OCUL
OCUL
Q4 25
21.4%
Q3 25
41.2%
Q2 25
9.3%
Q1 25
18.1%
Q4 24
1.2%
Q3 24
0.6%
Q2 24
4.5%
Q1 24
1.7%
Cash Conversion
KREF
KREF
OCUL
OCUL
Q4 25
Q3 25
1.34×
Q2 25
Q1 25
Q4 24
6.54×
Q3 24
Q2 24
1.19×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons